Antiabortion groups are increasingly turning against President Trump over continued access to abortion pills during his second term. Despite promises of stronger national restrictions after the fall of Roe v. Wade, the administration has left in place rules allowing mifepristone to be prescribed online and shipped across state lines. The conflict reflects a growing divide within the conservative movement over how far federal power should extend into reproductive healthcare. As abortion pills become central to the post-Roe landscape, the debate is shifting beyond legality toward questions of access, medical authority, and political control over reproductive care. Read more here.